Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Reeder

Showing results (411-420 of 465) with videos related to

Pageof 47
Sort By:
Leukemia Research|May 15, 2012
Allogeneic stem cell transplantation for myeloproliferative neoplasm in blast phaseChad Cherington, James L Slack, Jose Leis, et al.
Abdominal Radiology (New York)|November 30, 2019
Accuracy of common proton density fat fraction thresholds for magnitude- and complex-based chemical shift-encoded MRI for assessing hepatic steatosis in patients with obesityGuilherme Moura Cunha, Tydus T Thai, Gavin Hamilton, et al.
International Journal of Radiation Oncology, Biology, Physics|September 17, 2020
A Phase 1 Dose Escalation Study of Neoadjuvant SBRT Plus Elective Nodal Radiation with Concurrent Capecitabine for Resectable Pancreatic CancerJacob S Witt, Aleksandra Kuczmarska-Haas, Meghan Lubner, et al.
European Radiology|June 27, 2020
Gadoxetate-enhanced abbreviated MRI is highly accurate for hepatocellular carcinoma screeningNaik Vietti Violi, Sara Lewis, Joseph Liao, et al.
European Radiology|April 23, 2020
Prospective comparison of longitudinal change in hepatic proton density fat fraction (PDFF) estimated by magnitude-based MRI (MRI-M) and complex-based MRI (MRI-C)Adrija Mamidipalli, Kathryn J Fowler, Gavin Hamilton, et al.
Anti-Cancer Drugs|April 17, 2023
Daratumumab-lenalidomide and daratumumab-pomalidomide in relapsed lenalidomide-exposed or refractory multiple myelomaMuhamad Alhaj Moustafa, Ricardo Parrondo, Mays F Abdulazeez, et al.
Radiology|September 12, 2017
Linearity, Bias, and Precision of Hepatic Proton Density Fat Fraction Measurements by Using MR Imaging: A Meta-AnalysisTakeshi Yokoo, Suraj D Serai, Ali Pirasteh, et al.
Medical Physics|June 9, 2021
Multisite multivendor validation of a quantitative MRI and CT compatible fat phantomRuiyang Zhao, Diego Hernando, David T Harris, et al.
Leukemia & Lymphoma|October 15, 2020
Treatment facility volume and patient outcomes in Waldenstrom macroglobulinemiaMadugodaralalage D S K Gunaratne, Alexander J Sahakian, Jithma P Abeykoon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2014
Lenalidomide combined with R-CHOP overcomes negative prognostic impact of non-germinal center B-cell phenotype in newly diagnosed diffuse large B-Cell lymphoma: a phase II studyGrzegorz S Nowakowski, Betsy LaPlant, William R Macon, et al.
Pageof 47

Showing results (411-420 of 465) with videos related to

Sort By:
Pageof 47
Leukemia Research|May 15, 2012
Allogeneic stem cell transplantation for myeloproliferative neoplasm in blast phaseChad Cherington, James L Slack, Jose Leis, et al.
Abdominal Radiology (New York)|November 30, 2019
Accuracy of common proton density fat fraction thresholds for magnitude- and complex-based chemical shift-encoded MRI for assessing hepatic steatosis in patients with obesityGuilherme Moura Cunha, Tydus T Thai, Gavin Hamilton, et al.
International Journal of Radiation Oncology, Biology, Physics|September 17, 2020
A Phase 1 Dose Escalation Study of Neoadjuvant SBRT Plus Elective Nodal Radiation with Concurrent Capecitabine for Resectable Pancreatic CancerJacob S Witt, Aleksandra Kuczmarska-Haas, Meghan Lubner, et al.
European Radiology|June 27, 2020
Gadoxetate-enhanced abbreviated MRI is highly accurate for hepatocellular carcinoma screeningNaik Vietti Violi, Sara Lewis, Joseph Liao, et al.
European Radiology|April 23, 2020
Prospective comparison of longitudinal change in hepatic proton density fat fraction (PDFF) estimated by magnitude-based MRI (MRI-M) and complex-based MRI (MRI-C)Adrija Mamidipalli, Kathryn J Fowler, Gavin Hamilton, et al.
Anti-Cancer Drugs|April 17, 2023
Daratumumab-lenalidomide and daratumumab-pomalidomide in relapsed lenalidomide-exposed or refractory multiple myelomaMuhamad Alhaj Moustafa, Ricardo Parrondo, Mays F Abdulazeez, et al.
Radiology|September 12, 2017
Linearity, Bias, and Precision of Hepatic Proton Density Fat Fraction Measurements by Using MR Imaging: A Meta-AnalysisTakeshi Yokoo, Suraj D Serai, Ali Pirasteh, et al.
Medical Physics|June 9, 2021
Multisite multivendor validation of a quantitative MRI and CT compatible fat phantomRuiyang Zhao, Diego Hernando, David T Harris, et al.
Leukemia & Lymphoma|October 15, 2020
Treatment facility volume and patient outcomes in Waldenstrom macroglobulinemiaMadugodaralalage D S K Gunaratne, Alexander J Sahakian, Jithma P Abeykoon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2014
Lenalidomide combined with R-CHOP overcomes negative prognostic impact of non-germinal center B-cell phenotype in newly diagnosed diffuse large B-Cell lymphoma: a phase II studyGrzegorz S Nowakowski, Betsy LaPlant, William R Macon, et al.
Pageof 47